Advertisement

Topics

Search Results for "Orthophoenix Llc Medtornic Kyphon Patents"

17:13 EDT 4th May 2016 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

Dipexium Pharma gets Locilex patents in Australia and NZ

Dipexium Pharmaceuticals (NASDAQ:DPRX) said that Australia and New Zealand have issued new Locilex patents, with expiry dates in June 2033. The patents’ claims are directed to a novel formulatio...

Patents prompting ‘rebirth’ of innovation in industry

Seven pharma companies have been rated among the world’s 100 most innovative companies, according to Thomson Reuters. The business intelligence firm compiled a list of the top 100 global innovators ...

GMOs and Patents: Part 2 – Lawsuits against Farmers

This is the second of three posts examining the topic of GMOs and patents. The first post in the series provided an overview on the topic of patents and described the concept of “terminator genes...

GMOs and Patents: Part 1 – Terminator Genes

This is the first of three posts examining the topic of GMOs and patents. As the first post in the series, I’ll provide an overview on the topic of patents and will describe the concept of ̶...

Booby Prize: Why Replacing Patents With Prizes Would Harm Innovation

Presidential candidate Senator Sanders has proposed replacing patents with a government run scheme that offers prize money to innovators who create new medicines. This approach misunderstands the vita...

GMOs and Patents: Part 3 – Lawsuits for inadvertent contamination

This is the third and final post in a series examining the topic of GMOs and patents. The first post provided an overview on the topic of patents and described the concept of “terminator genes”....

Patent Score Card: Kyle Bass Gets 17 IPR Reviews Granted, 14 Denied

Bass wins review of four Acorda patents based on SEC registration filing; Patent Trial and Appeal Board declines to institute inter partes review of Enbrel patent and Insys' Subsys patents but okays t...

UPDATE 1-GlaxoSmithKline promises reduced drug patents to help world's poor

* GSK plans to pool patents on next-generation cancer drugs (Adds reaction, CEO comment on profits, country details)

Matching PubMed Articles

Novel methods to optimize the effects of transcranial direct current stimulation: a systematic review of transcranial direct current stimulation patents.

Transcranial direct current stimulation (tDCS) is a neuromodulatory technique that has been extensively studied. While there have been initial positive results in some clinical trials, there is still ...

Extending the market exclusivity of therapeutic antibodies through dosage patents.

Dosage patents are one way to extend the market exclusivity of an approved drug beyond the lifetime of the patent that protects the drug as such. Dosage patents may help to compensate the applicant fo...

Searching bioremediation patents through Cooperative Patent Classification (CPC).

Patent classification systems have traditionally evolved independently at each patent jurisdiction to classify patents handled by their examiners to be able to search previous patents while dealing wi...

FFA4/GPR120 agonists: a survey of the recent patent literature.

FFA4/GPR120, a member of the rhodopsin family of G-protein-coupled receptors (GPCRs), is becoming an important target for therapeutic intervention in several areas of disease, including metabolic dise...

Big Data from Pharmaceutical Patents: A Computational Analysis of Medicinal Chemists' Bread and Butter.

Multiple recent studies have focused on unraveling the content of the medicinal chemist's toolbox. Here, we present an investigation of chemical reactions and molecules retrieved from US patents over ...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement